Clinical profile and outcome of secondary glaucoma managed during the COVID-19 pandemic in a tertiary care institute

doi:10.12998/wjcc.v14.i11.119670

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

(31)

(32)

(0)

(524)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Cases. Apr 16, 2026; 14(11): 119670
Published online Apr 16, 2026. doi: 10.12998/wjcc.v14.i11.119670

Table 3 Secondary glaucoma presentation during coronavirus disease 2019 pandemic and post pandemic period, n (%)

	COVID-19	Post COVID-19	P value
Number of patients	62	82
Number of eyes affected	82	110	0.86
Male:female ratio	2.8:1	1.8:1	0.79
PXF	22 (26.8)	20 (18.2)	0.04
NVG	14 (17.1)	30 (27.3)
Traumatic	11 (13.4)	12 (10.9)
SIG	10 (12.2)	16 (14.5)
LIG	7 (8.5)	0 (0.00)
Developmental	5 (6.1)	9 (8.2)
Uveitic	4 (4.9)	10 (9.1)
Miscellaneous	9 (11.0)	13 (11.8)
Medical management in percentage	59 (71.9)	66 (60.0)	0.07
Surgical management in percentage	23 (28.1)	44 (40.00)
Mean IOP at presentation in mmHg	34.7 ± 10.46	35.2 ± 9.46	0.73
Mean IOP at 6 months in mmHg	16.65 ± 7.22	14.95 ± 6.45	0.087

IOP: Intraocular pressure; PXF: Pseudoexfoliation; LIG: Lens induced glaucoma; NVG: Neovascular glaucoma; SIG: Steroid induced glaucoma; COVID-19: Coronavirus disease 2019.

Full Size Table

Citation: Nayak B, Bhatt B, Parija S, Chakraborty K, Sahoo DP, Nanda J, Panda BB. Clinical profile and outcome of secondary glaucoma managed during the COVID-19 pandemic in a tertiary care institute. World J Clin Cases 2026; 14(11): 119670
URL: https://www.wjgnet.com/2307-8960/full/v14/i11/119670.htm
DOI: https://dx.doi.org/10.12998/wjcc.v14.i11.119670

Nayak B, Bhatt B, Parija S, Chakraborty K, Sahoo DP, Nanda J, Panda BB. Clinical profile and outcome of secondary glaucoma managed during the COVID-19 pandemic in a tertiary care institute. World J Clin Cases 2026; 14(11): 119670 [DOI: 10.12998/wjcc.v14.i11.119670]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.